Trial intelligence / Profile preview

Phase II randomized double-blind trial of PSD502 for pain in acute minor burns

2005-004653-96Phase 2Unknown

Sponsor
Plethora Solutions
Start
Dec 2005
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in burn injury comparing PSD502 with Placebo (2 arms). Primary endpoints: Retrospective VAPS pain score during procedure and Safety and tolerability of PSD502. Status: unknown.

02

Drugs

lidocaine + prilocaine
03

Conditions

burn injury

Beyond the preview

Go deeper on 2005-004653-96.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004653-96.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call